This proposal takes into consideration the ex vivo studies showing that SFRP2 may exert multiple other protective roles in different pathophysiological processes of cardiovascular disease, including inducing angiogenesis [31] and inhibiting cardiomyocyte apoptosis [32–34]. The gene discussed is SFRP2; the disease is cardiovascular disorder.